Startseite>>Signaling Pathways>> GPCR/G protein>> Glucocorticoid Receptor>>Fluocinonide

Fluocinonide (Synonyms: NSC 101791)

Katalog-Nr.GC10714

Fluocinonid (Vanos) ist ein starkes Glucocorticoid-Steroid, das topisch als entzÜndungshemmendes Mittel zur Behandlung von Hauterkrankungen verwendet wird.

Products are for research use only. Not for human use. We do not sell to patients.

Fluocinonide Chemische Struktur

Cas No.: 356-12-7

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
37,00 $
Auf Lager
100mg
59,00 $
Auf Lager
500mg
184,00 $
Auf Lager
1g
349,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Fluocinonide (Vanos) is a potent glucocorticoid steroid used topically as anti-inflammatory agent for the treatment of skin disorders.Target: Glucocorticoid ReceptorFluocinonide is a potent glucocorticoid steroid used topically as an anti-inflammatory agent for the treatment of skin disorders such as eczema and seborrhoeic dermatitis. Fluocinonide ranks as a "high-potency" topical corticosteroid. Minimal amounts should be used for a minimal length of time to avoid the occurrence of adverse effects. Fluocinonide should not be used if infection is present. Fluocinonide is used in veterinary medicine. It is a treatment for allergies in dogs. Natural systemic cortisol concentrations can be suppressed for weeks after one week of topical exposure. From Wikipedia.

References:
[1]. http://en.wikipedia.org/wiki/Fluocinonide

Bewertungen

Review for Fluocinonide

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Fluocinonide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.